Medicare Enrolled
Dr. Joshua June, DO
Internal Medicine · Lansing, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. June from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. June?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. June
Dr. Joshua June is an internal medicine specialist in Lansing, MI, with 16 years of NPI registration. Based on federal Medicare data, Dr. June performed 81,427 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. June received a total of $101,925 from 51 pharmaceutical and/or device companies across 1682 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. June is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 0% volume in MI
$101,925 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗81,427
Medicare services
Top 0% in MI for internal medicine
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
20,750 | $10 | $40 |
| Tocilizumab injection (Actemra) | 15,001 | $5 | $8 |
| Romosozumab injection (Evenity) for osteoporosis | 12,390 | $8 | $15 |
| Denosumab injection (Prolia/Xgeva) | 10,680 | $18 | $36 |
| Belimumab injection, 10 mg An injection of belimumab, a medication administered at a dose of 10 mg. |
7,972 | $39 | $65 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
7,750 | $33 | $66 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
2,150 | $64 | $132 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,087 | $88 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
453 | $10 | $65 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
431 | $1 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
390 | $62 | $135 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
273 | $27 | $86 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
258 | $45 | $190 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
210 | $93 | $270 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
207 | $21 | $120 |
| Anti-nausea injection (ondansetron/Zofran) | 200 | $0 | $4 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
173 | $49 | $200 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
144 | $8 | $20 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
142 | $11 | $95 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
109 | $36 | $150 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
100 | $9 | $30 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
95 | $6 | $50 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
91 | $4 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $127 | $230 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
43 | $54 | $205 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
43 | $29 | $50 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
42 | $43 | $221 |
| New patient office visit, complex (60-74 min) | 40 | $125 | $320 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
34 | $76 | $80 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 28 | $14 | $20 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
27 | $22 | $95 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
26 | $1 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $101 | $270 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
20 | $30 | $136 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
35.6% high complexity
61.5% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$101,925
Total received (2018-2024)
Avg $14,561/year across 7 years
Top 2% in MI for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,682
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,375
2023
$17,352
2022
$16,683
2021
$7,563
2020
$10,174
2019
$29,747
2018
$6,030
Payments by company (2024)
Janssen Biotech, Inc.
$10,692
ABBVIE INC.
$1,101
Amgen Inc.
$829
Novartis Pharmaceuticals Corporation
$280
Mallinckrodt Hospital Products Inc.
$268
UCB, Inc.
$263
AstraZeneca Pharmaceuticals LP
$173
ANI Pharmaceuticals, Inc.
$152
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
United Therapeutics Corporation
$115
Radius Health, Inc.
$52
Lilly USA, LLC
$51
Kiniksa Pharmaceuticals International, plc
$49
Organon Llc
$44
Merck Sharp & Dohme LLC
$26
SOBI, INC
$22
Alexion Pharmaceuticals, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$19
Sandoz Inc.
$18
Genentech USA, Inc.
$18
Arcutis Biotherapeutics, Inc.
$17
HOSPIRA, INC.
$14
Alvogen Inc
$14
Top 3 companies account for 87.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$30,615
Mallinckrodt Enterprises LLC
$23,094
Mallinckrodt Hospital Products Inc.
$11,334
Janssen Scientific Affairs, LLC
$9,584
Amgen Inc.
$4,145
Horizon Therapeutics plc
$2,769
ABBVIE INC.
$2,387
Mallinckrodt LLC
$2,072
UCB, Inc.
$1,806
E.R. Squibb & Sons, L.L.C.
$1,682
Fresenius Kabi USA, LLC
$1,601
Janssen Global Services, LLC
$1,500
Novartis Pharmaceuticals Corporation
$1,212
PFIZER INC.
$1,101
Genentech USA, Inc.
$823
AstraZeneca Pharmaceuticals LP
$793
Lilly USA, LLC
$643
Boehringer Ingelheim Pharmaceuticals, Inc.
$623
AbbVie Inc.
$586
Regeneron Healthcare Solutions, Inc.
$395
AbbVie, Inc.
$381
GlaxoSmithKline, LLC.
$350
Actelion Pharmaceuticals US, Inc.
$322
Celgene Corporation
$300
ANI Pharmaceuticals, Inc.
$238
United Therapeutics Corporation
$229
QIAGEN, LLC
$163
Aurinia Pharma U.S., Inc.
$132
JAZZ PHARMACEUTICALS INC.
$121
Radius Health, Inc.
$97
Flexion Therapeutics, Inc.
$80
Alexion Pharmaceuticals, Inc.
$79
Alvogen Inc
$78
Johnson & Johnson Health Care Systems Inc.
$67
Horizon Pharma plc
$61
Merck Sharp & Dohme LLC
$49
Kiniksa Pharmaceuticals International, plc
$49
SOBI, INC
$47
Organon Llc
$44
McKesson Specialty Care Distribution, LLC
$40
Boston Scientific Corporation
$38
Exeltis, USA Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$28
Organon LLC
$26
Sandoz Inc.
$18
Arcutis Biotherapeutics, Inc.
$17
Sobi, Inc
$16
Eisai Inc.
$15
HOSPIRA, INC.
$14
Bioventus LLC
$13
GENZYME CORPORATION
$12
Top 3 companies account for 63.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · CAPVAXIVE · CHANTIX · COSENTYX · CYLTEZO · Cimzia · Dayvigo · EVENITY · Enbrel · FORTEO · GELSYN 3 · HADLIMA · HUMIRA · HYQVIA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · PNEUMOVAX 23 · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIRIS · STELARA · STRENSIQ · SUNOSI · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · ULTOMIRIS · UPTRAVI · Uloric · Ultomiris · XELJANZ · Zilretta · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
238
County median income
$64,354
Nearest hospital to ZIP centroid (approximate)
MCLAREN GREATER LANSING
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. June is a mixed practice specialist, with above-average Medicare volume (top 0% in MI), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. June experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. June performed 20,750 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. June receive payments from pharmaceutical companies?
Yes. Dr. June received a total of $101,925 from 51 companies across 1,682 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. June's costs compare to other internal medicine physicians in Lansing?
Dr. June's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. June) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Lansing
Browse internal medicine physicians in Lansing ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MI
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MI
Which MI internal medicine physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Mallinckrodt Enterprises LLC Payments to Doctors
See all physicians who received payments from Mallinckrodt Enterprises LLC.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology